In multiple myeloma (MM), four Supertarget genes encode transcription factors such as interferon regulatory factor 4 (IRF4), PR/SET domain 1 (PRDM1), POU class 2 homeobox associating factor 1 (POU2AF1), and myocyte enhancer factor 2C (MEF2C, Figure 3B). This evidence concerns the gene MEF2C and Miyoshi myopathy.